MedicalResearch.com Interview with Dr. Boelens
Pediatric Blood and Marrow Transplantation Program,
University Medical Center Utrecht, Utrecht, Netherlands
MedicalResearch.com: What are the main findings of the study?
Dr. Boelens: For children with Hurler’s syndrome, the receipt of a hematopoietic cell transplant (HCT) early in life with the best available human leukocyte antigen (HLA)-matched donor offers the best event free survival (EFS). Also, HCT with a well matched unrelated cord blood unit is particularly attractive as the unit is readily available.
